| Name | 3-(6-ethyl-7-methoxy-5-methylimidazo[1,2-a]pyrimidin-2-yl)-5-methyl-1,2,4-oxadiazole |
|---|---|
| Synonyms |
UNII-XCA050IPGB
Fasiplon Fasiplon [INN] 6-ethyl-7-methoxy-5-methyl-2-(5-methyl-1,2,4-oxadiazol-3-yl)imidazo[1,2-a]pyrimidine |
| Density | 1.39g/cm3 |
|---|---|
| Molecular Formula | C13H15N5O2 |
| Molecular Weight | 273.29100 |
| Exact Mass | 273.12300 |
| PSA | 78.34000 |
| LogP | 1.96710 |
| Index of Refraction | 1.669 |
|
~93%
106100-65-6 |
| Literature: Roussel Uclaf Patent: US4703049 A1, 1987 ; |
|
~%
106100-65-6 |
| Literature: Tully; Gardner; Gillespie; Westwood Journal of Medicinal Chemistry, 1991 , vol. 34, # 7 p. 2060 - 2067 |
|
~%
106100-65-6 |
| Literature: Tully; Gardner; Gillespie; Westwood Journal of Medicinal Chemistry, 1991 , vol. 34, # 7 p. 2060 - 2067 |
|
~%
106100-65-6 |
| Literature: Tully; Gardner; Gillespie; Westwood Journal of Medicinal Chemistry, 1991 , vol. 34, # 7 p. 2060 - 2067 |
| Precursor 4 | |
|---|---|
| DownStream 0 | |